Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years

BACKGROUND: Metabolic bone diseases (MBD) are typically diagnosed by non-invasive imaging and clinical biomarkers. However, imaging does not provide structural information, and biomarkers can be transiently affected by many systemic factors. Bone biopsy and pathologic evaluation is the gold standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Colazo, Juan M., Quirion, Julia, Judice, Anthony D., Halpern, Jennifer, Schwartz, Herbert S., Tanner, S. Bobo, Lawrenz, Joshua M., Dahir, Kathryn M., Holt, Ginger E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558706/
https://www.ncbi.nlm.nih.gov/pubmed/37811524
http://dx.doi.org/10.1016/j.bonr.2023.101715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558706/
https://www.ncbi.nlm.nih.gov/pubmed/37811524
http://dx.doi.org/10.1016/j.bonr.2023.101715

Ejemplares similares